Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Dukoral suspension and effervescent powder for oral suspension, Cholera vaccine (inactivated, oral)

Active Ingredient:
vibrio cholerae, recombinant cholera toxin b subunit
Company:  
Valneva UK Limited See contact details
ATC code: 
J07AE01
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 18 Apr 2023

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PLGB 46066/0001.

Dukoral suspension and effervescent powder for oral suspension Cholera vaccine (inactivated, oral))

PACKAGE LEAFLET: INFORMATION FOR THE USER

DUKORAL® Suspension and effervescent powder for oral suspension

Cholera vaccine (inactivated, oral)

Read all of this leaflet carefully before you start using this vaccine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, nurse or pharmacist.
  • This vaccine has been prescribed for you only. Do not pass it on to others.
  • If you get any side effects, talk to your doctor, pharmacist or nurse.
    This includes any possible side effects not listed in this leaflet.
    See Section 4.
  • Make sure to mix the vaccine with buffer solution as described in this leaflet. See Section 3.

What is in this leaflet:

1. What Dukoral is and what it is used for
2. What you need to know before you use Dukoral
3. How to use Dukoral
4. Possible side effects
5. How to store Dukoral
6. Contents of the pack and other information

1. WHAT DUKORAL IS AND WHAT IT IS USED FOR

Dukoral is an oral vaccine against cholera that stimulates the immunological defence in the gut. The vaccine protects adults and children from 2 years of age against cholera.

Dukoral causes your body to produce its own protection against cholera.

After getting the vaccine, your body will make substances called anti- bodies, which fight the cholera bacteria and toxin that cause diarrhoea.

2. WHAT YOU NEED TO KNOW BEFORE YOU USE DUKORAL
Do not use Dukoral
  • if you are allergic to any ingredient of the vaccine or to formaldehyde.
  • if you have an acute stomach disorder or infection with fever (vaccination should be delayed).

Warnings and precautions

Talk to your doctor before taking Dukoral

  • if you take a medical treatment that affects the immune system
  • if you have a disease of the immune system (including HIV infection).

The vaccine may provide you with a lower level of protection than it does for people with healthy immune systems.

The vaccine does not provide complete protection and it is important to adhere to dietary and hygiene advice to avoid diarrhoeal diseases.

Children

Do not give this vaccine to children younger than 2 years since the protection has not been studied in this group.

Other medicines and Dukoral

Please tell your doctor if you are taking or have recently taken any other medicines.

Do not take other medicine starting 1 hour before until 1 hour after taking the vaccine.

Using Dukoral with food and drink

Avoid food and drink starting 1 hour before until 1 hour after the vaccination.

Pregnancy and breast-feeding

If you are pregnant, think you may be pregnant or are planning to have a baby or are breast-feeding, ask your doctor before taking the vaccine.

Driving and using machines

There are no reasons to suspect that Dukoral will affect your ability to drive or handle machines.

Dukoral contains sodium

Dukoral contains approximately 1.1 g sodium per dose. Please take this into consideration if you are on a controlled sodium diet.

3. 3. HOW TO USE DUKORAL

Always use this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor if you are not sure.

Adults and children from 6 years of age: The primary vaccination is 2 doses taken orally (by mouth) at least 1 week (up to 6 weeks) apart.

  • Take the 1st dose no later than 2 weeks before you leave for your trip.
  • Take the 2nd dose at least 1 week after the 1st dose and at least 1 week before your trip.

It takes about 1 week after the last dose for protection to begin.

For continuous protection, re-vaccination is recommended within 2 years.

If you had your last dose of vaccine less than 2 years ago a single dose will renew your protection. If more than 2 years have passed since you had the last vaccine dose, the primary vaccination (2 doses) should be repeated.

Children of 2 to below 6 years of age: The primary vaccination is 3 doses taken orally (by mouth) at least 1 week (up to 6 weeks) apart. Only half of the amount of the buffer solution should be mixed with the vaccine.

  • Give the 1st dose to the child no later than 3 weeks before you leave for your trip.
  • Give the 2nd dose to the child at least 1 week after the 1 dose.
  • Give the 3rd dose at least one week after the 2 dose and at least 1 week before your trip.

It takes about 1 week after the last dose for protection to begin.

For continuous protection, re-vaccination is recommended within 6 months.

If less than 6 months have passed since the last vaccination a single dose will renew the protection. If more than 6 months have passed since the last vaccination, the primary vaccination (3 doses) should be repeated.

The suspension supplied in a single-dose glass vial is a whitish suspension.

Each vial comes with one sachet package that contains a white effervescent powder of sodium hydrogen carbonate. The effervescent powder should be dissolved in a glass of cool water, and the resulting buffer solution should be mixed with the suspension. It is important to use the buffer solution, as it protects the vaccine from the gastric acid.

Drink the entire mixture within 2 hours after mixing with the buffer preparation.

Instructions for use:

1. To prepare the buffer solution, dissolve the effervescent powder in a glass of cool water (approx. 150 ml) by gently stirring.

Do not use any other liquid.

For children of 2 to below 6 years: pour away half of the buffer solution.

2. Shake the Dukoral® suspension vial (1 vial = 1 dose).

3. Pour the content of Dukoral® suspension vial into the glass of buffer solution (see 1).

Mix by gently stirring.

4. Drink the entire mixture within 2 hours.

Avoid food and drink starting 1 hour before until 1 hour after drinking the mixture.

If you take more Dukoral than you should

If you take the doses less than 1 week apart, contact your doctor, pharmacist or nurse.

Because each vial of Dukoral contains only one dose, overdosage is unlikely.

If you have taken more than one dose at one time, please contact your doctor, pharmacist or nurse.

If you forget to take Dukoral.

You can take the 2nd dose of Dukoral up to 6 weeks after the 1st dose (children of 2 to below 6 years have to take 3 doses). If more than 6 weeks have passed, contact your doctor, pharmacist or nurse.

If you have any further questions on the use of this vaccine, ask your doctor, pharmacist or nurse.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Dukoral can cause side effects, although not everybody gets them.

Contact a doctor immediately if you experience the following serious side effects:

  • severe diarrhea with loss of water from the body
  • serious allergic reactions causing swelling of the face or throat and breathlessness

Other side effects:

Uncommon side effects (may affect up to 1 in a 100 people)

  • Diarrhoea, stomach pain, stomach cramps, gurgling stomach, bloated stomach, stomach gas and general stomach discomfort
  • Headache

Rare side effects (may affect up to 1 in a 1,000 people)

  • Fever
  • Generally feeling unwell, feeling dizzy
  • Nausea (feeling sick), vomiting, loss of /or poor appetite
  • Swelling irritation inside the nose, and cough

Very rare side effects (may affect up to 1 in a 10,000 people)

  • Rash
  • Sore throat, reduced sense of taste
  • Fatigue/feeling tired
  • Sweating, shivering
  • Joint pain
  • Difficulty in sleeping

Other side effects (frequency cannot be estimated from the available data)

  • Flu -like symptoms, chestiness, chills, general pain, weakness
  • Hives, itching
  • Swelling of the lymph glands
  • Numbness or pins and needles
  • High blood pressure

Reporting of side effects

If you get any side effects, talk to your your doctor, nurse or pharmacist.

This includes any possible side effects not listed in this leaflet. You can also report side effects directly to:

Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard

or search for MHRA Yellow Card in the Google Play or Apple App Store.

5. HOW TO STORE DUKORAL

Keep this medicine out of the sight and reach of children.

Do not use Dukoral after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

Store in a refrigerator (2 °C–8 °C). Do not freeze.

Product in the unopened vial and sachet, stored in the outer carton, is stable at temperatures up to 25 °C for a period of 14 days. At the end of this period the product should be used or discarded.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Dukoral contains
  • The active substances are:
    31.25x109 bacteria* of each of the following V. cholerae 01 strains:
    Inaba classical biotype (heat inactivated), Inaba El Tor biotype (formalin inactivated), Ogawa classical biotype (heat inactivated), Ogawa classical biotype (formalin inactivated).
    Recombinant cholera toxin B subunit (rCTB) 1 mg.
    *bacterial content prior to inactivation
  • The other ingredients in the vaccine suspension are sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride and water for injections.
  • The effervescent powder contains sodium hydrogen carbonate, citric acid, sodium carbonate, saccharin sodium, sodium citrate and raspberry flavour.

What Dukoral looks like and contents of the pack

Dukoral is presented as a suspension and effervescent powder for oral suspension. The suspension is a whitish suspension supplied in a vial. The effervescent powder is white with a raspberry flavour and is supplied in a sachet.

Dukoral is available in packs of 1, 2 and 20 doses. Not all pack sizes may be marketed.

Marketing Authorisation Holder
Valneva Sweden AB
105 21 Stockholm
Sweden

Manufacturer
Valneva Sweden AB
Gunnar Asplunds allé 16
SE-171 69 Solna
Sweden

This leaflet was last revised in 01/2021

Valneva Sweden AB
105 21 Stockholm
Sweden

SV40466-

Valneva UK Limited
Company image
Address
Centaur House, Ancells Business Park, Ancells Road, Fleet, GU51 2UJ, UK
Medical Information Direct Line
+ enquiries +44 (0)1506 446 608
Medical Information e-mail
[email protected]
Adverse event reporting email
[email protected]